M&A Deal Summary

Endo International Acquires Paladin Labs

On May 11, 2013, Endo International acquired life science company Paladin Labs for 1.6B USD

Acquisition Highlights
  • This is Endo International’s 5th transaction in the Life Science sector.
  • This is Endo International’s 4th largest (disclosed) transaction.
  • This is Endo International’s 1st transaction in Canada.
  • This is Endo International’s 1st transaction in Quebec.

M&A Deal Summary
Date 2013-05-11
Target Paladin Labs
Sector Life Science
Buyer(s) Endo International
Deal Type Add-on Acquisition
Deal Value 1.6B USD
Advisor(s) Credit Suisse Investment Banking (Financial)
Davies Ward Phillips & Vineberg LLP (Legal)

Target

Paladin Labs

Saint-Laurent, Quebec, Canada
website
Paladin Labs, Inc., is a pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian and world markets.

Search 193,240 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Endo International

Dublin, Ireland

website

Category Company
Founded 1920
Sector Medical Products
Employees3,103
Revenue 2.9B USD (2020)
DESCRIPTION

Endo International is a pharmaceutical company engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used to treat and manage pain, bladder cancer, prostate cancer and the early onset of puberty in children, or central precocious puberty (CPP). Endo International was incorporatted in 1920 and is based in Dublin, Ireland.

DEAL STATS #
Overall 9 of 16
Sector (Life Science) 5 of 11
Type (Add-on Acquisition) 9 of 15
State (Quebec) 1 of 1
Country (Canada) 1 of 1
Year (2013) 1 of 2
Size (of disclosed) 4 of 14
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-06-20 American Medical Systems

Minnetonka, Minnesota, United States

American Medical Systems, Inc. is a manufacturer and marketer of medical devices for the surgical treatment of urological and gynecological disorders.

Buy $2.9B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-08-28 Boca Pharmacal

Coral Springs, Florida, United States

Boca Pharmacal, Inc. provides medical products like tablets and capsules.

Buy $225M
Mergr

Product

Company

Legal